Ziwen Zhu

7PUBLICATIONS
56CO-AUTHORS
Neural engineeringHaematological tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2026
Autophagy inhibition sensitizes radiotherapy responses in high-grade mutant IDH1 glioma.

|Aug 20, 2026
A dual pronged approach to cancer immune exclusion: tumor-derived LAIR-1 simultaneously drives fibrosis and blocks immune recruitment in glioma.

|Feb 06, 2026
MIF-mediated reprogramming of myeloid lineage within the glioma tumor microenvironment impacts the efficacy of immune stimulatory gene therapy.

Ziwen Zhu, Noah C Kanis, Anthony E George

|Nov 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy.

Brandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb

|Jul 03, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas.

Maria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee

|Jan 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.

Stephen V Carney, Kaushik Banerjee, Anzar Mujeeb

Pageof 2

Frequent Collaborators

4 joint publications

Pedro R Lowenstein

4 joint publications

Joshua Welch

3 joint publications

Maria G Castro

2 joint publications

Maureen A Sartor